Rosa Giuliani
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Innovative oncology trial designs: Time to act - A review with recommendations of the Cancer Drug Development Forum.
Journal: Journal of cancer policy
Published: December 02, 2025
Accelerating cancer treatment optimisation: A multistakeholder roadmap from the Cancer Medicines Forum.
Journal: Journal of cancer policy
Published: September 13, 2025
Avoiding Error and Finding the Right Balance in European Health Technology Assessments: Insights Generated by the European Access Academy.
Journal: Journal of market access & health policy
Published: September 04, 2024
The Role of Medical Societies and the Relevance of Clinical Perspective in the Evolving EU HTA Process: Insights Generated at the 2023 Fall Convention and Survey of the European Access Academy.
Journal: Journal of market access & health policy
Published: January 30, 2024
An Inclusive Civil Society Dialogue for Successful Implementation of the EU HTA Regulation: Call to Action to Ensure Appropriate Involvement of Stakeholders and Collaborators.
Journal: Journal of market access & health policy
Published: October 11, 2023
The role of stakeholder involvement in the evolving EU HTA process: Insights generated through the European Access Academy's multi-stakeholder pre-convention questionnaire.
Journal: Journal of market access & health policy
Published: June 07, 2023
Neoadjuvant Trastuzumab and Pertuzumab for Early HER2-Positive Breast Cancer: A Real World Experience.
Journal: The breast journal
Published: September 26, 2021
Preparing for the incoming wave of biosimilars in oncology.
Journal: ESMO open
Published: July 11, 2018
Safety analysis, association with response and previous treatments of everolimus and exemestane in 181 metastatic breast cancer patients: A multicenter Italian experience.
Journal: Breast (Edinburgh, Scotland)
Published: January 23, 2016
Last Updated: 09/26/2026